Amanote Research
Register
Sign In
Oncolytic Viruses: Immune or Cytolytic Therapy?
Molecular Therapy
- United States
doi 10.1038/mt.2014.94
Full Text
Open PDF
Abstract
Available in
full text
Categories
Molecular Medicine
Molecular Biology
Pharmacology
Medicine
Genetics
Drug Discovery
Date
July 1, 2014
Authors
John Bell
Publisher
Elsevier BV
Related search
An Overview on Oncolytic Viruses as Cancer Therapy
International Journal of Cancer Studies & Research
Micromanaging Oncolytic Viruses
Science-Business eXchange
Oncolytic Viruses Partner With T-Cell Therapy for Solid Tumor Treatment
Frontiers in Immunology
Allergy
Immunology
Oncolytic Viruses: Overcoming Translational Challenges
Journal of Clinical Investigation
Medicine
Using Clinically Approved Cyclophosphamide Regimens to Control the Humoral Immune Response to Oncolytic Viruses
Gene Therapy
Molecular Medicine
Genetics
Molecular Biology
Achieving Systemic Delivery of Oncolytic Viruses
Expert Opinion on Drug Delivery
Pharmaceutical Science
Triple Threat to Cancer: Rationale for Combining Oncolytic Viruses, MEK Inhibitors, and Immune Checkpoint Blockade
OncoImmunology
Oncology
Allergy
Immunology
Oncolytic Viruses: A Step Into Cancer Immunotherapy
Virus Adaptation and Treatment
Virology
Infectious Diseases
Immunology
Sensitivity of Breast Tumors to Oncolytic Viruses